It’s Commercialization, not patenting The New UM Tech Transfer Jim O’Connell Director OTT.

Slides:



Advertisements
Similar presentations
Overview of the Keys to Successful Commercialization Gerald J. Siuta, Ph.D. President Siuta Consulting, Inc. Tucson, Arizona October 18, 2001.
Advertisements

IP Impact on Funding - Perspectives from the Field Castel Commercialization of Academic Research Key Considerations in Securing Funding Early Stage Collaborative.
Technology and Economic Development Intellectual Property Issues in Research Jim Baker Director Office of Technology and Economic Development
CONFIDENTIAL © 2012 Barnes & Thornburg LLP. All Rights Reserved. This page, and all information on it, is confidential, proprietary and the property of.
Patent or Perish? Presented By: John F. Letchford Archer & Greiner, P.C. October 19, 2006.
Building on Research Innovation A new resource in the Faculty of Science since Spring 2006.
IP Issues in Research Jim Baker, Executive Director Innovation, and Industry Engagement.
Charles D. Smith, Ph.D. April, 2012.
North Carolina State University © 2014 Technology Transfer Outcomes February 27, 2014 Research Retreat Kelly B. Sexton, Ph.D. Director Office of Technology.
LOWER SHORE TECHNOLOGY TRANSFER SYMPOSIUM Bringing the Benefits of Discovery to the World MAY 23, 2012 Wesley D. Blakeslee Executive Director Johns Hopkins.
So you’ve invented something? A Guide for UMass Faculty, Researchers and Students.
The Catholic University of America Office of Technology Transfer Office of Technology Transfer Commercialization of CUA-Developed Technologies February.
NanoString: From Research to Start-Up Amber Ratcliffe Co-founder of NanoString Technologies October 23 rd, 2008.
Intellectual Property: Kenneth Kirkland, Ph.D. Executive Director, Iowa State University Research Foundation (ISURF) Director, Office of Intellectual Property.
Innovations at U of T the business of ideas Presentation to the Institute for Optical Sciences December 1 st, 2006 Dr. Cyril Gibbons Director, Commercialization.
Sustainable Smart Cities Symposium April 3, 2013 Richard B. Marchase Vice President for Research and Economic Development.
1 Wildcat Venture Management Technology Transfer Tactics Audio Panel September 30, 2008 Chicago, IL Copyright © 2008 Wildcat Venture Management, Inc.
Management of Intellectual Property at Iowa State University Contributing to Economic Development Kenneth Kirkland, Ph.D. Executive Director, Iowa State.
Digital Enterprise Research Institute Digital Enterprise Research Institute – Connecting with Industry Mr. Michael Turley, CEO
University Startup Best Practices Presentation for Technology Transfer Tactics April 15 th, 2009.
EURECA Program ITMO-UCLA strategic partnership Results of the phase I Nikolai R. Toivonen Nizhny Novgorod, November 28 th, 2012.
Photo by hernandezfisher - Creative Commons Attribution-NonCommercial-ShareAlike License with Haiku.
The UMass Entrepreneurship Commons May 19, Objectives: to strengthen the entrepreneurial culture on the UMass campuses; to increase participation.
Overview OTL Mission Inventor Responsibility Stanford Royalty Sharing Disclosure Form Patent View Inventor Agreements Patent.
Synapse and Catapult– New NIH OTT Technology Transfer Tools Ajoy K. Prabhu, M.S., M.B.A. Group Leader, Marketing Office of Technology Transfer National.
KUIC - Copyright 2014 KU Innovation and Collaboration (KUIC) is the commercialization arm of the University of Kansas (all campuses): Intellectual property.
The Business of Technology Baker & McKenzie LLP Tamsen Valoir, Ph.D. Baker & McKenzie International is a Swiss Verein with member law firms around the.
Technology Commercialization: Tech Transfer and Beyond.
Copyright © 2013 NC IDEA Carolina Innovations Seminar Attracting Investors through Winning Grants February 7, 2013.
+ Faculty Orientation UAMS BioVentures September 23, 2015 Christopher A. Fasel Associate Director of Licensing Patent Attorney UAMS BioVentures.
Life Science Venture Capital 11th Annual NIH SBIR/STTR Conference July 1, 2009 Randy H. Weiss, Ph.D. Partner, Triathlon Medical Ventures.
Invention Disclosure Analysis / Triage. Overview Decision making Components of an invention disclosure Review process Qualitative factors – art vs. science.
University Technology Transfer: Issues and Opportunities Mark Crowell Research Administration for Scientists (T. Quigg) 7 December 2001.
Introduction to the Offices of Biotechnology & Business Development John L. Harb Director, Office of Biotechnology __________________________________ October.
03/10/2008 Terese Rakow, PhD. Postdoctoral Career Development Course March 10, 2008.
University of Rochester Technology Development Fund OTT F.I.R.E. Series - March 10, Michael G. Rusnak, Fund Manager Deputy Director New Ventures.
Tech Launch Arizona Tech Transfer Arizona David Allen, PhD, VP Tech Launch Arizona Rakhi Gibbons, Asst. Director for Biomedical and Life Sciences Licensing.
VentureLab Harold H. Shlevin, PhD Principal – Bioscience O: C:
Office of Technology Commercialization Chuck Rancourt Director.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
Innovation Acceleration Partner Fellows Program Approaches to Improving Commercialization and Innovation National Science Foundation Partner for Innovation.
Technology Transfer at Case Western Reserve University Casey Porto, Assoc. V. P.
1 Columbia University Office of the General Counsel March 2012 Columbia University Office of the General Counsel Patenting Biotech: Strategies and Tips.
Translation and Innovation Mark Chance, PhD Vice Dean for Research School of Medicine October 19, 2015.
Evices Software Research Tools Therapeutics Diagnostics Medical Devices Software Research Tools Therapeutics Diagnostics Medic s Startup Technology Transfer.
UAB’s Life Sciences Entrepeneurship Program David Anthony, UAB’s MBA for Scientists Lisa Schwiebert,
NATIONAL CONFERENCE Intellectual Property Policies for Universities and Innovation dr. sc. Vlatka Petrović Head, Technology Transfer Office Acting Head,
2011 Calendar Important Dates/Events/Homework. SunSatFriThursWedTuesMon January
Intellectual Property at USC October 27, 2003 Dr. Michael Muthig.
HOW DO PATENTING AND LICENSING AFFECT RESEARCH? JOAN S. LEONARD VICE PRESIDENT AND GENERAL COUNSEL HOWARD HUGHES MEDICAL INSTITUTE The National Academies.
Introduction – Innovation & Entrepreneurship Programs on Campus Snapshot of Innovation In India The Innovation Landscape Opportunity for Universities,
Vermont's 21st Century Economy: Building an Entrepreneurial Ecosystem Dr. Corine Farewell Director, Office of Technology Commercialization University of.
1 Catapult Corporation: Venture Philanthropy Creating Managed Investment Capital for Extraordinary Companies Created at the University of Arizona David.
Caribbean Regional Entrepreneurial Asset Commercialisation Hub REACH.
OTC FELLOWS PROGRAM INFORMATION SESSION Fall 2016.
Taking Discoveries from Lab to the Market
So you’ve invented something?
IP, Invention Disclosures and Commercialization
Cleantech to Market Technology Transfer at Berkeley Lab
I have an idea, now what! What’s the process?
Gestora brasileiro focada exclusivamente na área da saúde.
Partnering with Business and Industry
Lunch & Learn “Startup’s & E.I.R’s”
Tamar Raz, PHD.
MSU’s place for connecting to the private sector
MSU’s place for connecting to the private sector
MONETIZING IP and TECH TRANSFER The Patent Attorney’s Perspective
2019 Hagerstown Technology Showcase March 21, 2019
2015 January February March April May June July August September
Managing Milestones for University Startups
Presentation transcript:

It’s Commercialization, not patenting The New UM Tech Transfer Jim O’Connell Director OTT

> $3M Spent

Old OTT

New OTT

Me Aero Engineer RPI, MS Eng Mgt, U of Maryland USAF Helicopter Pilot – Rescue, Spec Ops Stryker – Biz and Product Development – 30 project launches 2 Startups – Med Device 2 Patents Umich Tech Transfer

16 years of experience in tech commercialization UF OTL U of Saskatchewan ILO PhD in molecular biology Member of the NY Bar Structured hundreds of licensing/strategic alliance deals Bin Yan

Mike Davis M.S. Science & Technology Entrepreneurship Worked with inventors at all stages of the invention- development continuum, i.e. concept to commercialization Performed both, buy-side & sell-side due diligence Primary focus – Medical Devices

Daniel J. Catron EDUCATION VENTURES EXPERIENCE Novelios Pharmaceuticals Basic and applied science background with emphasis on immunology, ophthalmology, virology, bioinformatics, and cancer biology Co-founded two startups Executive, management, and consulting experience

How OTT is commercializing Business experienced licensing people Patenting less Better law firms = better patents EIRs Earlier Engagement Idea Portal/ Web Invention Disclosure Working on funds for early stage companies

Deals Done Omnis Pharma Sublicense to Medimmune– Glen Barber Trisaq Sublicense to Miltenyi – Jochen Reiser Seattle Genetics Adcetris – Eckhard Podack Millipore – Multiple Malek, Barber, Podack

How do I get to a deal?

Web-based Idea & Invention Portal

Need a collaborator? We can connect you!

What OTT will do for you Engage Earlier Educate Edit papers/abstracts for IP Get industry feedback on research Find potential SRA partners Provide EIR Map out your path to a product If it makes sense, help you start a company

Advice We’ll help with IP Ownership and Inventorship Coordinate with ORA and COI Equity – what’s market FDA path Reimbursement Copyright Company Funding Changes to patent law Finding a CEO

Patenting and Publish or Perish Old: “I have novel idea, I must patent it before I publish.” New: “I have a novel idea with data that supports a practical, publically beneficial application that has reasonable potential to create a revenue stream that will at least justify the patenting expense. Let’s plan a patenting and business strategy.”

New Paradigm for Faculty Less patenting Patent enablement = proof that it works Need to see viable commercial path Need business plan to go with that path Need commitment from faculty, what are your expectations? Idea portal

Advanced Topics…. SBIR/STTR - More $ Annually than VCs NIH Phase 0 - NIH Coulter Program NIH Reach Grants – Collaboration Ecosystem NIH iCorps – Biz bootcamp for faculty Rokk3r Labs – Local Software Biz Dev Subsidized Lab Space at LSTP POC Funds – Prototyping Equity Funds – Seed funds

C2C Seven things every academic should know about patents February 26, 2015 Building commercial software: It has to work 100% of the time March 24, 2015 Ten steps to forming a startup company to commercialize your novel results April 28, 2015 Funding your start-ups: perspectives from angel investors and VCs May 26, 2015 Evolving patenting strategies for genes, biomarkers and products of nature June 30, 2015

Inventorship vs Authorship vs Ownership July 28, 2015 Technology marketing: beating the bushes August 25, 2015 Academic startups: entrepreneur perspectives September 29, 2015 University policies relating to technology transfer and commercialization October 27, 2015 Protecting and commercializing novel software November 17, 2015 Don’t overlook “small items”: commercializing research reagents December 7, 2015

AIA, we lost 12 months and more First to file, sort of As important, provisionally filed claims need to be definitive Publish or perish, publish without making IP public And, I’m sorry, every idea you come up with is not novel………

Patent Costs Provisional - $ $8, US Utility - $10,000 - $15,000 Canada - $8,000 - $12,000 Europe Only - $20,000 - $30,000 Japan Only - $20,000 - $30,000 World Wide Nationalization Per Patent Pursued- >$100,000

Process 510(k)

Process IND

The real timelines

The real process

The real timelines